↓ Skip to main content

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Overview of attention for article published in New England Journal of Medicine, July 2019

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Readers on

mendeley
685 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 301 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 685 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 685 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 90 13%
Other 69 10%
Student > Ph. D. Student 64 9%
Student > Postgraduate 41 6%
Student > Master 38 6%
Other 102 15%
Unknown 281 41%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 196 29%
Biochemistry, Genetics and Molecular Biology 73 11%
Pharmacology, Toxicology and Pharmaceutical Science 37 5%
Agricultural and Biological Sciences 25 4%
Chemistry 9 1%
Other 47 7%
Unknown 298 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 393. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2026.
All research outputs
#99,055
of 34,823,064 outputs
Outputs from New England Journal of Medicine
#2,585
of 38,790 outputs
Outputs of similar age
#1,557
of 391,152 outputs
Outputs of similar age from New England Journal of Medicine
#37
of 233 outputs
Altmetric has tracked 34,823,064 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,790 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 391,152 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 233 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.